Stem cell transplant for severe scleroderma improves survival.

Stem cell transplant for severe scleroderma improves survival, quality of life New medical trial findings show a therapeutic regimen involving transplantation of someone’s personal blood-forming stem cells can improve survival and standard of living for those who have serious scleroderma, a life-threatening autoimmune Adisease ? . The program, referred to as myeloablative autologous hematopoietic stem cell transplant , contains chemotherapy and total body rays to demolish the bone tissue marrow accompanied by transplantation of the individuals very own blood-forming stem cells to reconstitute the marrow and disease fighting capability. The scholarly study, funded with the Country wide Institutes of Wellness, discovered myeloablative HSCT to become more advanced than treatment using the immune-suppressing medication cyclophosphamide.